Medtech

  • Scientists develop Covid-19 antibody measuring tech

    Do a person’s antibodies work to block the Covid-19 virus from infecting their system? Are these antibodies also capable of blocking emerging variants such as the Omicrons? These are the questions that researchers at George Mason University have set out to answer. A cross-disciplinary team, coordinated by scientists at the university's Center for Infectious Disease Research, [...]

  • Sheffield Hallam announces businesses for health tech accelerator

    Sheffield Hallam University has welcomed 12 national and international SMEs onto its accelerator programme. The health tech businesses will receive up to £20,000 of support to accelerate product development and help bring new health products and services to market. The accelerator brokers academic expertise from across the university to deliver R&D support to businesses. The [...]

  • Biodegradable gel keeps cancer at bay

    A new biodegradable gel improves the immune system's ability to keep cancer at bay after tumours are surgically removed. The gel, tested in mice, releases drugs and antibodies that deplete immune-blocking macrophages from the area and activate T cells so they can attack cancer. University of Wisconsin–Madison scientists tested the gel on mouse models of [...]

  • M1 MedTech accelerator opens for applications

    The M1 MedTech accelerator is inviting early-stage medical device companies to apply to its autumn programme. The programme is sponsored by Proxima Clinical Research, a contract research organisation (CRO) based out of the Texas Medical Center. M1 MedTech is looking for between five and seven of the most promising early-stage medical device companies to participate [...]

  • Pioneering test to protect babies from hearing loss

    How new rapid genomic test at Manchester University NHS Foundation Trust hospitals could prevent at-risk neonates from potential lifelong hearing loss.

  • Otivio extends exploratory MS clinical trial with FlowOx

    Norwegian health tech firm Otivio has extended an exploratory clinical trial which could lead to a breakthrough in treatment options for multiple sclerosis (MS).  The company has extended its trial with Neuro-SysMed to confirm the potential of its non-invasive FlowOx medical device to alleviate multiple sclerosis symptoms. The trial follows a recent case series of 7 people with [...]

  • What are the most fundamental lab safety rules?

    Whatever a laboratory researches or produces, safety is a crucial consideration. Without adequate safety measures, even the most innocuous activities can end up putting staff at risk, with the dangers only increasing as more dangerous materials, substances and pieces of equipment are used. Whether you work in a lab, manage one or hope to do [...]

  • Roche and Bristol Meyers Squibb sign digital diagnosis pact

    Big Pharma heavyweights Roche and Bristol Myers Squibb (BMS) are joining forces in two clinical trials to finesse digital pathway algorithms. Data from both trials will be used in cancer diagnosis and to boost personalised healthcare treatment options. Under the pact, Roche Digital Pathology is creating an AI-based image analysis algorithm to help pathologists interpret [...]

  • Programmable button drives faster heart attack care – study

    Shaving critical minutes off the time it takes to diagnose a heart attack and begin treatment could be as simple as the push of a button. Using a programmable button to page a phlebotomist for a blood draw reduced the time it took to identify patients suffering a heart attack by more than 11 minutes [...]

  • Patients to rank medics’ performance using new tech tool

    Patients across the globe will be able to rank their treatment and experience at the hands of doctors thanks to a new benchmarking gauge. Launched by Doctify - which operates a comparison site for patients and medics - the tool uses sentiment analysis to allow healthcare providers to see where they rank in terms of [...]